According to @WhiteHouse, President Biden reaffirmed on May 12, 2025, the administration’s strategy to lower prescription drug prices in the US to match the lowest global rates. This policy is expected to increase downward pressure on pharmaceutical stock prices, as margins may shrink due to enforced lower pricing (source: @WhiteHouse). For crypto traders, this could lead to sector rotation out of healthcare equities and into alternative assets, including cryptocurrencies, as investors seek higher yields and risk diversification. Monitoring pharma stock volatility and related ETF flows will be critical for anticipating capital movement into the crypto market after regulatory actions (source: @WhiteHouse, 2025).

According to The White House, President Donald J. Trump announced an upcoming Executive Order to reverse the Biden administration's policy on paper straws, potentially impacting the market for plastic straw manufacturers. This policy shift is expected to increase demand for plastic straws, potentially boosting the stock prices of related manufacturing companies.